Factor VIII related antigen in platelets of patients with Von Willebrand's disease

Contact activation and factor VII after the use of an activated prothrombin complex concentrate (FEIBA) in hemophiliacs with inhibitors.

Thrombosis research·2010

Role of isoleucine residues 182 and 183 in thrombin-activatable fibrinolysis inhibitor.

Journal of thrombosis and haemostasis : JTH·2005

Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide.

Journal of thrombosis and haemostasis : JTH·2005

Tumor growth and metastasis are not affected in thrombin-activatable fibrinolysis inhibitor-deficient mice.

Journal of thrombosis and haemostasis : JTH·2004

Impaired healing of cutaneous wounds and colonic anastomoses in mice lacking thrombin-activatable fibrinolysis inhibitor.

Journal of thrombosis and haemostasis : JTH·2003

Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).

Journal of thrombosis and haemostasis : JTH·2003

Contemporary anticoagulation management in pulmonary embolism.

Thrombosis research·2026

Left atrial appendage isolation and thrombotic and thromboembolic outcomes in atrial fibrillation: A systematic review and meta-analysis.

Thrombosis research·2026

Age-related reduction in D-dimer cut-off specificity: Diagnostic relevance in geriatric patients.

Thrombosis research·2026

Differential inhibition of bispecific GPVI and CLEC-2 nanobody ligands by a monovalent nanobody.

Thrombosis research·2026

Polygenic risk scores in predicting bleeding complications during oral anticoagulant therapy.

Thrombosis research·2026

Repetitive pulmonary embolism with local innate immune activation induces chronic thromboembolic pulmonary disease: A translational porcine study.

Thrombosis research·2026

Proton Pump Inhibitor Use Was Not Associated With Reduced Gastrointestinal Bleeding Risk in Ischemic Stroke Patients Treated With Dual Antiplatelet Therapy.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026

Aneurysmal subarachnoid hemorrhage: predictive score for angiographic vasospasm.

Arquivos de neuro-psiquiatria·2026

Platelet GPVI drives fibrotic lung remodeling.

Blood advances·2026

Blood clot contraction depends on spatial distribution of fibrin, red blood cells and platelets.

Journal of the mechanical behavior of biomedical materials·2026

Temporal morphological differentiation of menstrual and peripheral bloodstains on a semi-porous substrate: A controlled stereo-microscopic study.

Journal of forensic and legal medicine·2026

Interventional Management of Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis: Are There Differences Between East and West?

Current oncology reports·2026

Related Experiment Videos

Factor VIII related antigen in platelets of patients with Von Willebrand's disease

Related Concept Videos

Contact activation and factor VII after the use of an activated prothrombin complex concentrate (FEIBA) in hemophiliacs with inhibitors.

Role of isoleucine residues 182 and 183 in thrombin-activatable fibrinolysis inhibitor.

Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide.

Tumor growth and metastasis are not affected in thrombin-activatable fibrinolysis inhibitor-deficient mice.

Impaired healing of cutaneous wounds and colonic anastomoses in mice lacking thrombin-activatable fibrinolysis inhibitor.

Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).

Contemporary anticoagulation management in pulmonary embolism.

Left atrial appendage isolation and thrombotic and thromboembolic outcomes in atrial fibrillation: A systematic review and meta-analysis.

Age-related reduction in D-dimer cut-off specificity: Diagnostic relevance in geriatric patients.

Differential inhibition of bispecific GPVI and CLEC-2 nanobody ligands by a monovalent nanobody.

Polygenic risk scores in predicting bleeding complications during oral anticoagulant therapy.

Repetitive pulmonary embolism with local innate immune activation induces chronic thromboembolic pulmonary disease: A translational porcine study.

Proton Pump Inhibitor Use Was Not Associated With Reduced Gastrointestinal Bleeding Risk in Ischemic Stroke Patients Treated With Dual Antiplatelet Therapy.

Aneurysmal subarachnoid hemorrhage: predictive score for angiographic vasospasm.

Platelet GPVI drives fibrotic lung remodeling.

Blood clot contraction depends on spatial distribution of fibrin, red blood cells and platelets.

Temporal morphological differentiation of menstrual and peripheral bloodstains on a semi-porous substrate: A controlled stereo-microscopic study.

Interventional Management of Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis: Are There Differences Between East and West?

Related Experiment Videos

Factor VIII related antigen in platelets of patients with Von Willebrand's disease

Related Concept Videos

Related Articles